{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T10:10:36Z","timestamp":1774779036958,"version":"3.50.1"},"reference-count":72,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t              https:\/\/ror.org\/01h0zpd94","award":["62302088"],"award-info":[{"award-number":["62302088"]}]},{"name":"National Natural Science Foundation of China\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t              https:\/\/ror.org\/01h0zpd94","award":["62373093"],"award-info":[{"award-number":["62373093"]}]},{"name":"National Natural Science Foundation of China\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t              https:\/\/ror.org\/01h0zpd94","award":["62202094"],"award-info":[{"award-number":["62202094"]}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"crossref","award":["YQ2024F001"],"award-info":[{"award-number":["YQ2024F001"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Postdoctoral Program of Heilongjiang Province of China","award":["LBH-TZ2303"],"award-info":[{"award-number":["LBH-TZ2303"]}]},{"name":"the Postdoctoral Program of Heilongjiang Province of China","award":["LBH-Z23066"],"award-info":[{"award-number":["LBH-Z23066"]}]},{"name":"the Postdoctoral Program of Heilongjiang Province of China","award":["LBH-Z22065"],"award-info":[{"award-number":["LBH-Z22065"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Acute myeloid leukemia (AML) is an aggressive hematologic malignancy characterized by profound molecular heterogeneity and high relapse rates, posing significant clinical challenges. Programmed cell death (PCD), encompassing diverse regulated modalities such as apoptosis, necroptosis, and ferroptosis, plays a key role in leukemogenesis and therapeutic response; however, a comprehensive prognostic framework integrating multi-modal PCD pathways in AML remains elusive. In this study, we performed a systematic transcriptomic analysis of 1624 genes associated with 13 distinct PCD forms. A novel computational pipeline combining a variational autoencoder (VAE) for dimensionality reduction and a multilayer perceptron (MLP) for classification was employed to identify robust PCD-related biomarkers, interpreted via SHapley Additive exPlanations (SHAP) analysis. This approach identified 48 candidate genes with discriminative potential between AML and normal bone marrow. Unsupervised consensus clustering based on these genes delineated two molecular subtypes exhibiting divergent clinical outcomes and immune microenvironment profiles. The subtype demonstrated an immunosuppressive phenotype, characterized by enriched regulatory T cells, M2 macrophages, and elevated expression of inhibitory immune checkpoints, correlating with inferior survival. We developed an 8-gene prognostic signature (SORL1, PIK3R5, RIPK3, ELANE, GPX1, VNN1, CD74, and IL3RA) that effectively categorized patients into high- and low-risk groups with notable survival differences, validated across independent cohorts. A prognostic nomogram combining the risk score, age, and cytogenetic risk enhanced the prediction accuracy for overall survival. Our study presents an integrative model that connects multi-modal PCD pathways to AML prognosis, offering a new molecular subtyping system and a clinically applicable risk assessment tool for improved prognostication and personalized treatment strategies.<\/jats:p>","DOI":"10.3390\/cimb48040354","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:33:33Z","timestamp":1774622013000},"page":"354","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Leveraging Deep Learning to Construct a Programmed Cell Death-Driven Prognostic Signature in Acute Myeloid Leukemia"],"prefix":"10.3390","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8546-9665","authenticated-orcid":false,"given":"Chunlong","family":"Zhang","sequence":"first","affiliation":[{"name":"College of Computer and Control Engineering, Northeast Forestry University, Harbin 150040, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haisen","family":"Ni","sequence":"additional","affiliation":[{"name":"College of Computer and Control Engineering, Northeast Forestry University, Harbin 150040, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Computer and Control Engineering, Northeast Forestry University, Harbin 150040, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Computer and Control Engineering, Northeast Forestry University, Harbin 150040, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","article-title":"Biology and relevance of human acute myeloid leukemia stem cells","volume":"129","author":"Thomas","year":"2017","journal-title":"Blood"},{"key":"ref_2","first-page":"e70043","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Amoozgar, B., Bangolo, A., Habibi, M., Cho, C., and Goy, A. (2025). From Molecular Precision to Clinical Practice: A Comprehensive Review of Bispecific and Trispecific Antibodies in Hematologic Malignancies. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26115319"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41467-020-20491-8","article-title":"Imaging dynamic mTORC1 pathway activity in vivo reveals marked shifts that support time-specific inhibitor therapy in AML","volume":"12","author":"Oki","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1172\/JCI129204","article-title":"Immune escape and immunotherapy of acute myeloid leukemia","volume":"130","author":"Vago","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.2019001982","article-title":"How I treat relapsed or refractory AML","volume":"136","author":"DeWolf","year":"2020","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.molcel.2012.06.007","article-title":"A class of allosteric caspase inhibitors identified by high-throughput screening","volume":"47","author":"Feldman","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/cdd.2011.75","article-title":"Peculiarities of cell death mechanisms in neutrophils","volume":"18","author":"Geering","year":"2011","journal-title":"Cell Death Differ."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","article-title":"Ferroptosis, necroptosis, and pyroptosis in anticancer immunity","volume":"13","author":"Tang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1021\/acscentsci.0c01592","article-title":"Inhibiting Ferroptosis through Disrupting the NCOA4-FTH1 Interaction: A New Mechanism of Action","volume":"7","author":"Fang","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1126\/science.abo3959","article-title":"Copper-induced cell death","volume":"375","author":"Kahlson","year":"2022","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ctrv.2013.07.008","article-title":"Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death","volume":"40","author":"Wen","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/bph.12416","article-title":"Parthanatos: Mitochondrial-linked mechanisms and therapeutic opportunities","volume":"171","author":"Fatokun","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1242\/jcs.091181","article-title":"Lysosomal cell death at a glance","volume":"126","author":"Aits","year":"2013","journal-title":"J. Cell Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/2159-8290.CD-19-0292","article-title":"Targeting Autophagy in Cancer: Recent Advances and Future Directions","volume":"9","author":"Amaravadi","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2017.12.004","article-title":"JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice","volume":"154","author":"Song","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coi.2018.10.006","article-title":"Oxeiptosis: A discreet way to respond to radicals","volume":"56","author":"Scaturro","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.3874430","article-title":"Involvement of the bcl-2 gene in human follicular lymphoma","volume":"228","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/cdd.2014.222","article-title":"Necroptosis suppresses inflammation via termination of TNF- or LPS-induced cytokine and chemokine production","volume":"22","author":"Kearney","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"eadi1782","DOI":"10.1126\/sciadv.adi1782","article-title":"RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells","volume":"10","author":"Zhu","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Xia, Y., Jin, Y., Cui, D., Wu, X., Song, C., Jin, W., and Huang, H. (2022). Antitumor Effect of Simvastatin in Combination with DNA Methyltransferase Inhibitor on Gastric Cancer via GSDME-Mediated Pyroptosis. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.860546"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Jiao, Y., Wang, H., Zhu, M., Liu, T., Li, Y., Yang, S., Zhang, M., and Zhang, L. (2025). Copper-induced cell death mechanisms and their role in the tumor microenvironment. Front. Cell Death, 4.","DOI":"10.3389\/fceld.2025.1628470"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12964-022-00897-1","article-title":"Inhibition of AKT induces p53\/SIRT6\/PARP1-dependent parthanatos to suppress tumor growth","volume":"20","author":"Zhang","year":"2022","journal-title":"Cell Commun. Signal"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/cr.2014.137","article-title":"Induction of entosis by epithelial cadherin expression","volume":"24","author":"Sun","year":"2014","journal-title":"Cell Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.cell.2007.10.040","article-title":"A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion","volume":"131","author":"Overholtzer","year":"2007","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e183544","DOI":"10.1172\/JCI183544","article-title":"5-HT orchestrates histone serotonylation and citrullination to drive neutrophil extracellular traps and liver metastasis","volume":"135","author":"Liu","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4161\/auto.5774","article-title":"Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation","volume":"4","author":"Ostenfeld","year":"2008","journal-title":"Autophagy"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2005.07.002","article-title":"Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy","volume":"122","author":"Pattingre","year":"2005","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12964-024-01871-9","article-title":"Disulfidptosis: A novel cell death modality induced by actin cytoskeleton collapse and a promising target for cancer therapeutics","volume":"22","author":"Li","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"106936","DOI":"10.1016\/j.ijsu.2022.106936","article-title":"Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery","volume":"107","author":"Zou","year":"2022","journal-title":"Int. J. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/path.5028","article-title":"PanCancer insights from The Cancer Genome Atlas: The pathologist\u2019s perspective","volume":"244","author":"Cooper","year":"2018","journal-title":"J. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1182\/blood-2007-09-113027","article-title":"Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia","volume":"111","author":"Tomasson","year":"2008","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"39098","DOI":"10.18632\/oncotarget.5390","article-title":"An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype","volume":"6","author":"Chuang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","article-title":"From Local Explanations to Global Understanding with Explainable AI for Trees","volume":"2","author":"Lundberg","year":"2020","journal-title":"Nat. Mach. Intell."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41598-023-51108-x","article-title":"Immune, metabolic landscapes of prognostic signatures for lung adenocarcinoma based on a novel deep learning framework","volume":"14","author":"Qin","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_42","first-page":"100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Hanzelmann, S., Castelo, R., and Guinney, J. (2013). GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform., 14.","DOI":"10.1186\/1471-2105-14-7"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: A class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: Digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Sendker, S., Reinhardt, D., and Niktoreh, N. (2021). Redirecting the Immune Microenvironment in Acute Myeloid Leukemia. Cancers, 13.","DOI":"10.3390\/cancers13061423"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: An R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief. Bioinform."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB Signaling: Navigating the Network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10238-025-01795-9","article-title":"The AML immune paradox: Decoding escape pathways and pioneering checkpoint, vaccine, and combination strategies","volume":"25","author":"Shafiei","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cytogfr.2018.08.004","article-title":"The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators","volume":"43","author":"Binder","year":"2018","journal-title":"Cytokine Growth Factor. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.critrevonc.2004.10.012","article-title":"The molecular pathogenesis of acute myeloid leukemia","volume":"56","author":"Steffen","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"8420","DOI":"10.18632\/oncotarget.14220","article-title":"Sensitizing leukemia stem cells to NF-kappaB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Nepstad, I., Hatfield, K.J., Gronningsaeter, I.S., and Reikvam, H. (2020). The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082907"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic Classification and Prognosis in Acute Myeloid Leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1513257","article-title":"Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia","volume":"374","author":"Roberts","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1056\/NEJMoa1002315","article-title":"Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia","volume":"362","author":"Kantarjian","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"112634","DOI":"10.1016\/j.isci.2025.112634","article-title":"Cytohesin-4\/ARF6 facilitates the progression of acute myeloid leukemia through activating PIK3R5\/PI3K\/AKT pathway","volume":"28","author":"Qiu","year":"2025","journal-title":"iScience"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccell.2016.06.002","article-title":"RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells","volume":"30","author":"Hockendorf","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"166268","DOI":"10.1016\/j.bbadis.2021.166268","article-title":"GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression","volume":"1868","author":"Zhang","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12935-025-03962-0","article-title":"Cellular and molecular features of acute myeloid leukemia investigation based on single-cell RNA sequencing","volume":"25","author":"Li","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1002\/ajh.24925","article-title":"Vanin 1 (VNN1) levels predict poor outcome in acute myeloid leukemia","volume":"93","author":"Izzi","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.cca.2012.06.025","article-title":"Circulating soluble LR11\/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias","volume":"413","author":"Sakai","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.3324\/haematol.2023.283757","article-title":"CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: A report from the Children\u2019s Oncology Group","volume":"109","author":"Menssen","year":"2024","journal-title":"Haematologica"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s12185-019-02616-y","article-title":"Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia","volume":"109","author":"Arai","year":"2019","journal-title":"Int. J. Hematol."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/4\/354\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T04:12:54Z","timestamp":1774757574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/4\/354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":72,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["cimb48040354"],"URL":"https:\/\/doi.org\/10.3390\/cimb48040354","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]}}}